ETC
SAGE

Exchange Traded Concepts’s Sage Therapeutics SAGE Stock Holding History

Exchange Traded Concepts’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,663
Closed -$140K – 1261
2022
Q4 		$140K Buy
3,663
+914
+33% +$34.9K ﹤0.01% 736
2022
Q3 		$108K Buy
2,749
+346
+14% +$13.4K ﹤0.01% 740
2022
Q2 		$78K Buy
2,403
+1,555
+183% +$52.1K ﹤0.01% 827
2022
Q1 		$28K Buy
+848
New +$31.9K ﹤0.01% 997
2021
Q3 		– Sell
-285
Closed -$16K – 1214
2021
Q2 		$16K Buy
+285
New +$20.1K ﹤0.01% 1000
2021
Q1 		– Sell
-8,539
Closed -$739K – 1144
2020
Q4 		$739K Buy
+8,539
New +$629K 0.03% 271

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return